Latest News about TGTX
Recent news which mentions TGTX
   These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
   
  
  
  May 02, 2022
  From MarketWatch
 
   FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
   
  
  
  April 21, 2022
  From Benzinga
 From InvestorPlace
 
   68 Biggest Movers From Yesterday
   
  
  
  April 19, 2022
  From Benzinga
 
   Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
   
  
  
  April 18, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  April 18, 2022
  From Benzinga
 From Benzinga
 
   34 Stocks Moving In Monday's Mid-Day Session
   
  
  
  April 18, 2022
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  April 18, 2022
  From Benzinga
 
   10 Biggest Price Target Changes For Monday
   
  
  
  April 18, 2022
  From Benzinga
 
   21 Stocks Moving in Monday's Pre-Market Session
   
  
  
  April 18, 2022
  From Benzinga
 
   The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
   
  
  
  April 17, 2022
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  April 12, 2022
  From Benzinga
 From Benzinga
 
   Stocks That Hit 52-Week Lows On Tuesday
   
  
  
  March 15, 2022
  From Benzinga
 
   FDA Pushes TG Therapeutics' Ublituximab / Ukoniq Combo Therapy Applications In Blood Cancer Settings
   
  March 03, 2022
  Tickers 
   TGTX
  
  
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For March 1, 2022
   
  
  
  March 01, 2022
  From Benzinga
 
   52 Biggest Movers From Friday
   
  
  
  January 31, 2022
  From Benzinga
 
   64 Biggest Movers From Yesterday
   
  
  
  January 28, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Intraday Session
   
  
  
  January 27, 2022
  From Benzinga
 
   TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold On Blood Cancer Trials
   
  January 27, 2022
  Tickers 
   TGTX
  
  
  From Benzinga
 
   46 Stocks Moving In Thursday's Mid-Day Session
   
  
  
  January 27, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

